Subscribe To
seagen 3q revenue beat driven by jump in product sales
seagen reported mixed third quarter earnings, with revenue outperforming expectations on strong product...
November 1, 2023, 12:11 pm
Pfizer to sees no major m&a activity in 2024: ceo bourla
Pfizer Chairman and CEO Albert Bourla says the company is still in the market for acquisitions following its $43 billion acquisition of cancer biotech...
October 31, 2023, 3:30 pm
Pfizer stock: interesting, if discipline returns
Pfizer Inc.'s acquisition of seagen is the latest in a series of M&A deals fueled by pandemic-related p...
October 23, 2023, 1:19 pm
Pfizer wins unconditional eu antitrust okay for $43 bln seagen buy
U.S. pharmaceutical company Pfizer gained unconditional EU antitrust approval on Thursday for its proposed $43 billion acquisition of cancer drug make...
October 19, 2023, 10:54 am
Top trending biotech stocks: anvs, mtnb, avtx, tpst
Biotech stocks are some of the most volatile in the market because of the regular FDA updates and mergers and acquisitions in the industry. Some of th...
October 12, 2023, 11:26 am
Exxon eyeing pioneer in possible $60bn acquisition
Experts estimate that such an acquisition could be worth as much as $60bn. They would be Exxon’s most significant endeavour since the $81bn merger w...
October 6, 2023, 9:53 am
Immunome: the morphimmune merger and the pipeline
IMNM is set to merge with Morphimmune, pending a shareholder vote on September 29. The current CEO of Morphimmune, Clay Siegall, would become the new ...
September 28, 2023, 3:11 pm
Signal says buy calls on this biotech stock
Biotech stock seagen Inc (NASDAQ:SGEN) scored an all-time high of $215.04 today, building on a Friday...
September 25, 2023, 2:32 pm
Seagen's (sgen) combo drug meets goals in bladder cancer study
seagen (SGEN) announces positive top-line results from its late-stage study of the Padcev/Keytruda comb...
September 25, 2023, 12:01 pm
Seagen-merck bladder cancer treatment shows positive results; seagen shares jump
Biotechnology company seagen Inc. (SGEN) and Tokyo-based Astellas Pharma Inc. on Friday reported positi...
September 22, 2023, 12:40 pm
Eu antitrust regulators set oct. 19 deadline for pfizer's seagen deal
Pfizer's $43 billion bid for seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory...
September 15, 2023, 2:15 pm
Nurix (nrix) stock increases 9% in a month: here's why
The upside in Nurix's (NRIX) shares can be attributed to the company's recently signed collaboration with seag...
September 11, 2023, 1:32 pm
Merck & co., inc. (mrk) citi 18th annual biopharma conference (transcript)
Merck & Co., Inc. (NYSE:MRK ) Citi 18th Annual BioPharma Conference September 6, 2023 1:50 PM ET Company Participants Marjorie Green - SVP and Head of...
September 6, 2023, 6:40 pm
Zai lab adr surges after seagen, genmab release cervical cancer treatment results
Zai Lab Ltd.'s American depositary receipts ZLAB, +2.47% jumped 14% premarket on Tuesday after seagen I...
September 5, 2023, 8:12 am
Genmab, seagen say tivdak cervical cancer trial met overall survival endpoint
Genmab A/S , and seagen Inc on Monday said that the Phase III trial of Tivdak in recurrent or metastati...
September 4, 2023, 5:33 pm
Seagen's (sgen) breast cancer study on tuksya combo meets goal
seagen (SGEN) announces positive top-line results from its breast cancer study evaluating Tuksya in com...
August 17, 2023, 11:46 am
Seagen's breast cancer therapy meets main goal in late-stage study
seagen said on Wednesday its breast cancer therapy in combination with Roche's Kadcyla helped extend th...
August 16, 2023, 8:34 am
Ftc wants to block the amgen-horizon deal: is pfizer's acquisition of seagen at risk, too?
There isn't much overlap between Amgen's business and Horizons', but that isn't stopping the FTC from looking to block the deal. Pfizer has a strong o...
May 24, 2023, 5:15 am
Pfizer just took out $31 billion in debt. here's why that's good news
Pfizer is making its largest-ever debt issuance. It's going to use the proceeds to acquire Seagen....
May 22, 2023, 11:25 am
Is pfizer's seagen deal in jeopardy amid antitrust scrutiny?
Pfizer Inc. NYSE: PFE continued its downward trajectory on May 17, following news that the Federal Trade Commission is seeking to block Amgen Inc.'s N...
May 19, 2023, 7:18 am